Uroseptin shots after uterine adhesion surgery generally have no significant effect on the endometrium.
Urotropin is a gonadotropin that acts like follicle stimulating hormone to promote the development and maturation of follicles in women. It is commonly used clinically in conjunction with chorionic gonadotropin to induce ovarian ovulation for the treatment of anovulatory infertility.
Although developing follicles secrete estrogen, which promotes endometrial hyperplasia, this effect is minimal. In addition to this, the luteinizing hormone in uroseptin has a very small effect, so uroseptin shots have essentially no effect on the endometrium.
Clinically, women with a thin endometrium can be encouraged to thicken the endometrium through the use of estrogenic and progestational drugs, such as dextroprogesterone and estradiol.
If there is a need to prepare for pregnancy after uterine adhesion surgery, the menstrual cycle should be regulated under the guidance of the doctor and the follicles and uterine lining should be monitored regularly in order to achieve a better therapeutic effect. Consultation with your doctor is recommended for details.